Abbott Laboratories (LON: 0Q15)
London
· Delayed Price · Currency is GBP · Price in USD114.51
+1.23 (1.09%)
At close: Dec 20, 2024
Abbott Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Net Income | 5,767 | 5,723 | 6,933 | 7,071 | 4,495 | 3,687 | Upgrade
|
| Depreciation & Amortization | 3,224 | 3,243 | 3,267 | 3,538 | 3,327 | 3,014 | Upgrade
|
| Loss (Gain) From Sale of Assets | 126 | 126 | 215 | 55 | 425 | 184 | Upgrade
|
| Stock-Based Compensation | 676 | 644 | 685 | 640 | 546 | 519 | Upgrade
|
| Other Operating Activities | - | - | - | - | - | 63 | Upgrade
|
| Change in Accounts Receivable | -465 | -356 | -68 | -383 | -924 | -275 | Upgrade
|
| Change in Inventory | 2 | -232 | -1,413 | -456 | -493 | -593 | Upgrade
|
| Change in Accounts Payable | -760 | -760 | 420 | 1,288 | 1,766 | 220 | Upgrade
|
| Change in Income Taxes | -585 | -585 | -383 | -908 | -614 | -545 | Upgrade
|
| Change in Other Net Operating Assets | 743 | -542 | -75 | -312 | -627 | -138 | Upgrade
|
| Operating Cash Flow | 8,728 | 7,261 | 9,581 | 10,533 | 7,901 | 6,136 | Upgrade
|
| Operating Cash Flow Growth | 33.27% | -24.21% | -9.04% | 33.31% | 28.76% | -2.60% | Upgrade
|
| Capital Expenditures | -2,242 | -2,202 | -1,777 | -1,885 | -2,177 | -1,638 | Upgrade
|
| Cash Acquisitions | - | -877 | - | -187 | -42 | -170 | Upgrade
|
| Divestitures | 1 | 40 | 48 | 134 | 58 | 48 | Upgrade
|
| Investment in Securities | -62 | -116 | -33 | -96 | -73 | -82 | Upgrade
|
| Other Investing Activities | 7 | 22 | 22 | 26 | 19 | 27 | Upgrade
|
| Investing Cash Flow | -2,296 | -3,133 | -1,740 | -2,008 | -2,215 | -1,815 | Upgrade
|
| Short-Term Debt Issued | - | 21 | 47 | - | 2 | - | Upgrade
|
| Long-Term Debt Issued | - | 2 | 7 | 4 | 1,281 | 1,842 | Upgrade
|
| Total Debt Issued | 244 | 23 | 54 | 4 | 1,283 | 1,842 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -204 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2,498 | -753 | -48 | -1,333 | -3,441 | Upgrade
|
| Total Debt Repaid | -1,107 | -2,498 | -753 | -252 | -1,333 | -3,441 | Upgrade
|
| Net Debt Issued (Repaid) | -863 | -2,475 | -699 | -248 | -50 | -1,599 | Upgrade
|
| Issuance of Common Stock | 273 | 167 | 167 | 255 | 245 | 298 | Upgrade
|
| Repurchase of Common Stock | -1,239 | -1,227 | -3,795 | -2,299 | -403 | -718 | Upgrade
|
| Common Dividends Paid | -3,766 | -3,556 | -3,309 | -3,202 | -2,560 | -2,270 | Upgrade
|
| Other Financing Activities | - | - | - | - | -11 | - | Upgrade
|
| Financing Cash Flow | -5,595 | -7,091 | -7,636 | -5,494 | -2,779 | -4,289 | Upgrade
|
| Foreign Exchange Rate Adjustments | 12 | -23 | -122 | -70 | 71 | -16 | Upgrade
|
| Net Cash Flow | 849 | -2,986 | 83 | 2,961 | 2,978 | 16 | Upgrade
|
| Free Cash Flow | 6,486 | 5,059 | 7,804 | 8,648 | 5,724 | 4,498 | Upgrade
|
| Free Cash Flow Growth | 44.39% | -35.17% | -9.76% | 51.08% | 27.26% | -8.32% | Upgrade
|
| Free Cash Flow Margin | 15.74% | 12.61% | 17.88% | 20.08% | 16.54% | 14.10% | Upgrade
|
| Free Cash Flow Per Share | 3.71 | 2.89 | 4.42 | 4.83 | 3.20 | 2.53 | Upgrade
|
| Cash Interest Paid | 662 | 662 | 563 | 544 | 549 | 677 | Upgrade
|
| Cash Income Tax Paid | 1,476 | 1,475 | 1,864 | 1,941 | 970 | 930 | Upgrade
|
| Levered Free Cash Flow | 6,405 | 4,990 | 7,340 | 7,675 | 5,269 | 3,843 | Upgrade
|
| Unlevered Free Cash Flow | 6,769 | 5,389 | 7,689 | 8,009 | 5,610 | 4,262 | Upgrade
|
| Change in Net Working Capital | -360 | 809 | 182 | 37 | -500 | 606 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.